ZGZeynep Ülkü Gün

Zeynep Ülkü Gün

*This is an algorithmically generated author record based on publicly available information.

Zeynep Ülkü Gün has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • FACTORS AFFECTING MEROPENEM TROUGH LEVELS IN CRITICALLY ILL PATIENTS: A THERAPEUTIC DRUG MONITORING STUDY

    by Ahmet Çakır, Hasan Memiş, Zeynep Ülkü Gün, Eren Demirpolat, Deccane Düzenci, Murat Bıçakcıoğlu, Çiğdem Karakükcü

    Objective: This study primarily aimed to determine meropenem the trough level (Cmin) in intensive care unit (ICU), with an exploratory secondary aim of evaluating factors influencing Cmin and clinical cure.Material and Method: This prospective study included adult ICU patients receiving meropenem for ≥48 hours, and Cmin levels were measured using a ready-to-use ELISA kit.Result and Discussion: The study included 38 patients, 26 of whom were male. Mean meropenem Cmin value was found to be 0.40 ± 0.07 mg/l which is statistically different than the target value of 8 mg/l (p < 0.001). We found no statistically significant difference in mean Cmin between the patient groups whose creatinine clearance was smaller than 50 ml/min and not. Erythrocyte and hemoglobin values decreased after meropenem treatment compared to baseline (p < 0.05). C-Reactive Protein (CRP) decreased, and Sequential Organ Failure Assessment (SOFA) values increased after meropenem treatment (p < 0.001). Logistic regression in patients with Systemic Inflammatory Response Syndrome (SIRS) showed that only SOFA reduced the clinical cure rate (OR 0.534, 95% CI 0.311–0.917). In this study, the target 100% fT > MIC < 4×MIC was not achieved with standard or extended meropenem infusion, potentially limiting clinical cure in ICUs with resistant pathogens, highlighting the need for alternative dosing strategies.

  • Smoking Behavior, Nicotine Dependence, and Awareness of Cessation Methods Among Pharmacy Students: A Cross-Sectional Analysis

    by Nesligül Özdemir-Ayduran, Nida Açar, Zeynep Ülkü Gün

    Determining the smoking behaviors of pharmacy students and the factors that influence these behaviors is important for public health, as they are future healthcare professionals. This study assessed the prevalence of nicotine dependence among pharmacy students, evaluated perceptions of smoking-cessation methods, and identified correlates of dependence. This cross-sectional survey was conducted at a Faculty of Pharmacy in eastern Türkiye between June–July 2022. An online 25-item questionnaire, developed based on the literature and expert input, was administered to the students. Students’ nicotine dependence was assessed using the Fagerström Test for Nicotine Dependence (FTND). The primary outcome was nicotine-dependence severity. Secondary outcomes were the prevalence of current smoking, FTND distributions by demographics, and perceived effectiveness of cessation methods. Data from 232 students were analyzed (median age 23 years; ~70% female). Of these, 121 (52.2%) had never smoked; 54 (23.3%) had tried once; 11(4.7%) were former smokers; 13 (5.6%) smoked occasionally; and 33 (14.2%) smoked daily. The median (IQR) value of the FTND score of active smokers was 3(4). Among 46 current smokers, the distribution of nicotine‐dependence levels were: very low: 22 (47.8%), low: 10 (21.7%), moderate: 3 (6.5%), high: 4(8.7%), and very high: 7 (15.2%). The presence of a family member who smoked led to an increase in the FTND Score (p=0.006). Face-to-face counseling and smoking cessation clinic interventions were rated significantly more effective than both mobile application and posters and printed educational materials (p

  • Open Access

    Development of a Liquid Chromatography-Tandem Mass Spectrometry Method for Quantifying Teicoplanin and Its Application in Critically Ill Patients

    by Hasan Memis, Ahmet Cakir, Zeynep Ulku Gun, Hatice Saracoglu, Cigdem Karakukcu, Aliye Esmaoglu, Zafer Dogan

    Healthcare-associated infections are frequently encountered in intensive care units (ICUs), with more than 30% of all ICU admissions having an infection. For decades, antibiotics have provided an effective treatment for infectious diseases. Since most antibiotic resistance is caused by misuse or abuse of antibiotics, one of the strategies that could


  • Open Access

    Evaluation of drug-related problems of intensive care unit patients by clinical pharmacists: a retrospective longitudinal study

    by Ahmet Çakır, Hasan Memiş, Zeynep Ülkü Gün, Murat Bıçakcıoğlu

    The study aimed to identify drug-related problems (DRPs) and risk factors associated with the emergence of DRPs in intensive care unit (ICU) patients. This retrospective study included patients in the anesthesiology and reanimation ICU of a university-affiliated tertiary care hospital. DRPs identified by clinical pharmacists were classified using the Pharmaceutical Care Network Europe Classification for DRPs version 9.1. The association between various patient-related factors, and having DRPs were evaluated. In total, 222 patients were included in the study, 128 of which were male (57.7%). The number of DRPs was 388 in 135 patients (1.75 ± 2.47 DRPs per patient). The group in which at least 1 DRP was identified, the duration of hospitalization was longer than in the group in which no DRP was identified (p < 0.001). In the groups in which there was the presence of mechanical ventilation support at admission or mortality, the mean DRP count was significantly higher than that in the other group (p < 0.05). Age, duration of hospitalization, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score at admission had positive relationships with the DRP count, but the Glasgow Coma Scale (GCS) showed a negative relationship (p < 0.05). According to the binary logistic regression analysis (p < 0.001), in which the age of the patient, GCS score, APACHE II score at admission, duration of hospitalization, and presence of mechanical ventilation support at admission were included, only the APACHE II score at admission and duration of hospitalization significantly affected the emergence of DRPs. The major problem was related to treatment effectiveness (47.9%), followed by treatment safety problems (29.9%). The major causes of these problems were dose selection (44.0%) and drug selection (36.8). Interventions were made at the drug (97.2%) and prescriber level (2.3%). The acceptance rate of interventions and resolution rate of the DRPs were 93.6% and 85.1%, respectively. The top three medications that caused DRPs the most were as follows: meropenem, colistin, and piperacillin/tazobactam. Clinical pharmacists can detect and treat DRPs quickly. Our analysis shows that clinical pharmacy services are needed in high-DRP wards like ICU.


  • Evaluation of Nutritional Needs of Intensive Care Unit Patients by Clinical Pharmacists

    by Ahmet Çakir, Hasan Memi̇ş, Zeynep Ülkü Gün

    Malnutrition in intensive care unit (ICU) patients affects disease progression and prolongs hospital stays. In this study, it was aimed to present the recommendations of clinical pharmacists in terms of nutrition in ICU patients. This study was conducted in the ICU between November 2022 and January 2023. Clinical pharmacists provided nutritional advice to patients according to current guidelines. Basal energy expenditure was calculated using the Harris-Benedict formula, and the most appropriate nutritional product was selected for the patients. Descriptive analyses were performed with SPSS v27.0. According to the reasons, the recommendation rates were categorized as feeding started (9,86%), feeding stopped (1,41%), feeding dose increased-reduced (28,17%), protein amount increased-reduced (35,21%), management of nutritional side effects (15,49%), and changes in administration (9,86%). Enema (54.54%) for constipation, prokinetic metoclopramide (36.36%), and discontinuation of parenteral nutrition due to hyperglycemia (9.09%) were recommended for the management of nutrition-related side effects. Examples of suggestions and explanations made regarding the nutritional status of the patients were given. In this study, recommendations were made for most ICU patients to eat more calories and protein. To avoid adverse effects, patients reached their calorie targets gradually. Clinical pharmacists can work with other healthcare professionals to prevent malnutrition-related problems.

  • Assessment of the Effects of Quince Seed Mucilage and Wheat Germ Oil on Wound Healing in Rats

    by Canan Çulha, Zeynep Ülkü Gün, Aysu Selçuk, Şule Api̇kOğlu-Rabuş

    Objective: People have used traditional herbal medicines for wound care since the dawn of time. This study aimed to assess the cutaneous wound healing effects of wheat germ oil (WGO) and quince seed mucilage (QSM) in rats. Methods: Adult female Wistar albino rats were allocated to one of the three groups: rats treated with topical WGO (n=6); topical QSM (n=6); and topical saline (n=6) as the control group. Two circular, full-thickness wounds of 0.6 mm diameter were created on the dorsal thoracic region of each rat. Test and control solutions were applied twice daily for 14 days. Wound healing was assessed by measuring the wound contraction rate and the time needed for complete epithelialization. Results: When compared with the control group, rats in the WGO group had reduced wound closure rates in the first four days, but considerably greater rates in the 8th, 10th, and 12th days, as well as a shorter duration of time needed to complete epithelialization (11 days vs. 13 days). The wound closure rates of the rats in the QSM group were not substantially different from the control rats and the duration of time needed for complete epithelialization was not significantly different from the control group. Conclusion: WGO use has been shown to improve wound healing. It may be used as an alternative or complementary approach for wound treatment depending on the severity of the wounds. On the other hand, QSM was not found to improve wound healing.


  • Evaluation of the Appropriateness of Antimicrobial Drug Dosages in Intensive Care Unit Patients

    by Hasan Memi̇ş, Ahmet Çakir, Nesligül Özdemi̇r, Zeynep Ülkü Gün

    The purpose of this study was to investigate the factors that required dose adjustments of antimicrobial drugs in intensive care unit (ICU) patients and to identify the drugs that required the most dose adjustments. The 26-bed reanimation ICU of a university-affiliated hospital hosted this study from September to December 2022. Two clinical pharmacists on duty examined patients' antimicrobial drug dosages daily. The acceptance status of the recommendations and the patients' demographic information were recorded. The study involved 133 ICU patients, and antimicrobial drug recommendations were made for 48 patients, 31 (64.6%) of whom were male. The median (IQR) age of the 48 patients was 67 (54–77). The number of recommendations was 94, and all of them were accepted by the physician. The recommendation rates according to the causes were: inappropriate dosages based on renal functions (71.3%), presence of continuous renal replacement therapy (11.7%), indication (10.6%), body weight (4.3%), and loading dose (2.1%). The top 3 drugs for which recommendations were made the most were colistin (21.3%), meropenem (18.1%), and piperacillin-tazobactam (12.8%). The most troublesome drug was colistin, which is frequently used to treat Acinetobacter pneumonia. Clinical pharmacist and physician collaboration may help rationalize ICU antimicrobial drug use.

  • DETERMINATION OF POTENTIAL DRUG-DRUG INTERACTIONS IN GENERAL PEDIATRIC WARD PATIENTS: A CROSS-SECTIONAL STUDY

    by Hasan Memi̇ş, Ahmet Çakir, Nesligül Özdemi̇r, Zeynep Ülkü Gün

    Objective: This study seeks to identify potential drug-drug interactions (pDDIs) in hospitalized patients and compare two commercial drug interaction databases. Material and Method: This prospective cross-sectional study was conducted between February and May 2022 in a tertiary care hospital's general pediatric ward. UpToDate® and Micromedex® Drug Interaction databases were used to determine pDDIs. Result and Discussion: In total, 267 pDDIs were found in 51 pediatric patients' medication lists (181 via UpToDate® and 86 via Micromedex®). The use of at least five different systemic drugs concurrently was statistically significant between groups of patients who experienced at least one pDDI and those who did not. The binary logistic regression analysis showed that a one-drug increase in the total number of drugs a patient received during hospitalization increased the probability of pDDIs by 2.12-fold (CI: 1.321-3.417, p=0.002). The concordance rate between UpToDate® and Micromedex® databases for pDDI determination was 84.31% (kappa coefficient=0.676, standard error=0.102, (p ≤ 0.001)). When the UpToDate® database was assumed as a reference database, the Micromedex® database's sensitivity, specificity, positive predictive value, negative predictive value, and accuracy in determining pDDIs were 79.41%, 94.12%, 96.43%, 69.56%, and 84.5%. To avoid missing pDDIs, utilizing multiple drug interaction databases may be of benefit.


  • Open Access

    The safety profile of favipiravir in COVID-19 patients with severe renal impairment

    by Selim Gök, Ömer Faruk Bahçecioğlu, Mefküre Durmuş, Zeynep Ülkü Gün, Yasemin Ersoy, Zeynep Ayfer Aytemur, Özkan Ulutaş

    Objective The safety profile of favipiravir in patients with severe renal impairment has not been investigated and available data are insufficient. The study aimed to compare the incidence of favipiravir-associated adverse events amongst patients with varying renal function statuses. Methods Records of 921 patients who were hospitalised for COVID-19 and had received at least 5 days of favipiravir treatment were retrospectively evaluated and 228 patients were included in the study. Patients' age, sex, comorbidities, estimated glomerular filtration rate (eGFR) and haematological and biochemical values were recorded. The incidence of adverse events was compared with the age, sex, comorbidities and eGFR of the patients. Results The mean age of the patients was 59.3 +/- 15.6 years, and 38.2% of the patients were women. One hundred and thirty-one (57.5%) patients had experienced adverse events. These adverse effects consisted of ALT elevation (35.5%), AST elevation (21.5%), anaemia (16.2%), hyperuricaemia (10.5%), hepatocellular injury (9.2%), neutropenia (3.5%) and thrombocytopenia (2.6%). The incidence of adverse events was not significantly different when patients had eGFR >60 mL/min/1.73 m(2) or eGFR 30-60 mL/min/1.73 m(2) (P > .05), but significantly increased when the eGFR dropped to <30 (P < .05). The differences seen with hyperuricaemia and anaemia were significant (P < .05). Conclusion Even though favipiravir appeared to be well tolerated in the individuals with renal failure in this study, its use in this population remains a challenge that requires more research and analysis.